Inspire Medical Systems (NYSE: INSP) reported Q1 EPS of ($0.34), $0.31 better than the analyst estimate of ($0.65). Revenue for the quarter came in at $164 million versus the consensus estimate of $161.41 million.

GUIDANCE:

Inspire Medical Systems sees FY2024 EPS of $0.10-$0.20, versus the consensus of ($0.42). Inspire Medical Systems sees FY2024 revenue of $783-793 million, versus the consensus of $782.1 million. The Company is maintaining its full year 2024 gross margin guidance of 83% to 85%.

For earnings history and earnings-related data on Inspire Medical Systems (INSP) click here.